Human Glioma-derived Interleukin-10 Inhibits Antitumor Immune Responses In Vitro
- 1 December 1995
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 37 (6) , 1160-1167
- https://doi.org/10.1227/00006123-199512000-00016
Abstract
INTRACRANIAL MALIGNANT GLIOMAS are sequestered from the immune system yet are associated with broad suppression of host immunocompetence. Immune systemKeywords
This publication has 27 references indexed in Scilit:
- Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide.The Journal of Experimental Medicine, 1993
- Interleukin‐10 production by human carcinoma cell lines and its relationship to interleukin‐6 expressionInternational Journal of Cancer, 1993
- Interferon gamma inhibits interleukin 10 production by monocytes.The Journal of Experimental Medicine, 1993
- Biological properties of interleukin 10Immunology Today, 1992
- Modulation of the Immune Response by Transforming Growth Factor BetaInternational Archives of Allergy and Immunology, 1992
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991
- Astrocytes and intracerebral immune responsesJournal of Clinical Immunology, 1989
- Immune‐Mediated Encephalitis: On the Role of Antigen‐Presenting Cells in Brain TissueImmunological Reviews, 1987
- Immunobiology of primary intracranial tumorsJournal of Neurosurgery, 1981